img

Global Nimodipine for Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nimodipine for Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Nimodipine for Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nimodipine for Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nimodipine for Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nimodipine for Injection key manufacturers include Shanxi PUDE Pharmaceutical, Reyoung Pharmaceutical, Double-Crane Pharmaceutical(Hainan), Shanxi Hengda Pharmaceutical, Kunming Longjin Pharmaceutical, Hainan Poly Pharm, Shanxi Zhendong Taisheng Pharmaceutical, Hainan Brilliant Pharmaceutical and Fujian Mindong Rejuenation Pharmaceutical, etc. Shanxi PUDE Pharmaceutical, Reyoung Pharmaceutical, Double-Crane Pharmaceutical(Hainan) are top 3 players and held % sales share in total in 2022.
Nimodipine for Injection can be divided into 2mg/Bottle and 4mg/Bottle, etc. 2mg/Bottle is the mainstream product in the market, accounting for % sales share globally in 2022.
Nimodipine for Injection is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy and Others,, etc. Hospital Pharmacy provides greatest supports to the Nimodipine for Injection industry development. In 2022, global % sales of Nimodipine for Injection went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nimodipine for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Shanxi PUDE Pharmaceutical
Reyoung Pharmaceutical
Double-Crane Pharmaceutical(Hainan)
Shanxi Hengda Pharmaceutical
Kunming Longjin Pharmaceutical
Hainan Poly Pharm
Shanxi Zhendong Taisheng Pharmaceutical
Hainan Brilliant Pharmaceutical
Fujian Mindong Rejuenation Pharmaceutical
Segment by Type
2mg/Bottle
4mg/Bottle

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nimodipine for Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nimodipine for Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nimodipine for Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Nimodipine for Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nimodipine for Injection introduction, etc. Nimodipine for Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Nimodipine for Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Nimodipine for Injection Market Overview
1.1 Nimodipine for Injection Product Overview
1.2 Nimodipine for Injection Market Segment by Type
1.2.1 2mg/Bottle
1.2.2 4mg/Bottle
1.3 Global Nimodipine for Injection Market Size by Type
1.3.1 Global Nimodipine for Injection Market Size Overview by Type (2024-2034)
1.3.2 Global Nimodipine for Injection Historic Market Size Review by Type (2024-2024)
1.3.3 Global Nimodipine for Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nimodipine for Injection Sales Breakdown by Type (2024-2024)
1.4.2 Europe Nimodipine for Injection Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Nimodipine for Injection Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Nimodipine for Injection Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Nimodipine for Injection Sales Breakdown by Type (2024-2024)
2 Global Nimodipine for Injection Market Competition by Company
2.1 Global Top Players by Nimodipine for Injection Sales (2024-2024)
2.2 Global Top Players by Nimodipine for Injection Revenue (2024-2024)
2.3 Global Top Players by Nimodipine for Injection Price (2024-2024)
2.4 Global Top Manufacturers Nimodipine for Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nimodipine for Injection Market Competitive Situation and Trends
2.5.1 Nimodipine for Injection Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Nimodipine for Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nimodipine for Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Nimodipine for Injection Market
2.8 Key Manufacturers Nimodipine for Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nimodipine for Injection Status and Outlook by Region
3.1 Global Nimodipine for Injection Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Nimodipine for Injection Historic Market Size by Region
3.2.1 Global Nimodipine for Injection Sales in Volume by Region (2024-2024)
3.2.2 Global Nimodipine for Injection Sales in Value by Region (2024-2024)
3.2.3 Global Nimodipine for Injection Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Nimodipine for Injection Forecasted Market Size by Region
3.3.1 Global Nimodipine for Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Nimodipine for Injection Sales in Value by Region (2024-2034)
3.3.3 Global Nimodipine for Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Nimodipine for Injection by Application
4.1 Nimodipine for Injection Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Others
4.2 Global Nimodipine for Injection Market Size by Application
4.2.1 Global Nimodipine for Injection Market Size Overview by Application (2024-2034)
4.2.2 Global Nimodipine for Injection Historic Market Size Review by Application (2024-2024)
4.2.3 Global Nimodipine for Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nimodipine for Injection Sales Breakdown by Application (2024-2024)
4.3.2 Europe Nimodipine for Injection Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Nimodipine for Injection Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Nimodipine for Injection Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Nimodipine for Injection Sales Breakdown by Application (2024-2024)
5 North America Nimodipine for Injection by Country
5.1 North America Nimodipine for Injection Historic Market Size by Country
5.1.1 North America Nimodipine for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Nimodipine for Injection Sales in Volume by Country (2024-2024)
5.1.3 North America Nimodipine for Injection Sales in Value by Country (2024-2024)
5.2 North America Nimodipine for Injection Forecasted Market Size by Country
5.2.1 North America Nimodipine for Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Nimodipine for Injection Sales in Value by Country (2024-2034)
6 Europe Nimodipine for Injection by Country
6.1 Europe Nimodipine for Injection Historic Market Size by Country
6.1.1 Europe Nimodipine for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Nimodipine for Injection Sales in Volume by Country (2024-2024)
6.1.3 Europe Nimodipine for Injection Sales in Value by Country (2024-2024)
6.2 Europe Nimodipine for Injection Forecasted Market Size by Country
6.2.1 Europe Nimodipine for Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Nimodipine for Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Nimodipine for Injection by Region
7.1 Asia-Pacific Nimodipine for Injection Historic Market Size by Region
7.1.1 Asia-Pacific Nimodipine for Injection Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Nimodipine for Injection Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Nimodipine for Injection Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Nimodipine for Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Nimodipine for Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Nimodipine for Injection Sales in Value by Region (2024-2034)
8 Latin America Nimodipine for Injection by Country
8.1 Latin America Nimodipine for Injection Historic Market Size by Country
8.1.1 Latin America Nimodipine for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Nimodipine for Injection Sales in Volume by Country (2024-2024)
8.1.3 Latin America Nimodipine for Injection Sales in Value by Country (2024-2024)
8.2 Latin America Nimodipine for Injection Forecasted Market Size by Country
8.2.1 Latin America Nimodipine for Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Nimodipine for Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Nimodipine for Injection by Country
9.1 Middle East and Africa Nimodipine for Injection Historic Market Size by Country
9.1.1 Middle East and Africa Nimodipine for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Nimodipine for Injection Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Nimodipine for Injection Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Nimodipine for Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Nimodipine for Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Nimodipine for Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Shanxi PUDE Pharmaceutical
10.1.1 Shanxi PUDE Pharmaceutical Company Information
10.1.2 Shanxi PUDE Pharmaceutical Introduction and Business Overview
10.1.3 Shanxi PUDE Pharmaceutical Nimodipine for Injection Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Shanxi PUDE Pharmaceutical Nimodipine for Injection Products Offered
10.1.5 Shanxi PUDE Pharmaceutical Recent Development
10.2 Reyoung Pharmaceutical
10.2.1 Reyoung Pharmaceutical Company Information
10.2.2 Reyoung Pharmaceutical Introduction and Business Overview
10.2.3 Reyoung Pharmaceutical Nimodipine for Injection Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Reyoung Pharmaceutical Nimodipine for Injection Products Offered
10.2.5 Reyoung Pharmaceutical Recent Development
10.3 Double-Crane Pharmaceutical(Hainan)
10.3.1 Double-Crane Pharmaceutical(Hainan) Company Information
10.3.2 Double-Crane Pharmaceutical(Hainan) Introduction and Business Overview
10.3.3 Double-Crane Pharmaceutical(Hainan) Nimodipine for Injection Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Double-Crane Pharmaceutical(Hainan) Nimodipine for Injection Products Offered
10.3.5 Double-Crane Pharmaceutical(Hainan) Recent Development
10.4 Shanxi Hengda Pharmaceutical
10.4.1 Shanxi Hengda Pharmaceutical Company Information
10.4.2 Shanxi Hengda Pharmaceutical Introduction and Business Overview
10.4.3 Shanxi Hengda Pharmaceutical Nimodipine for Injection Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Shanxi Hengda Pharmaceutical Nimodipine for Injection Products Offered
10.4.5 Shanxi Hengda Pharmaceutical Recent Development
10.5 Kunming Longjin Pharmaceutical
10.5.1 Kunming Longjin Pharmaceutical Company Information
10.5.2 Kunming Longjin Pharmaceutical Introduction and Business Overview
10.5.3 Kunming Longjin Pharmaceutical Nimodipine for Injection Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Kunming Longjin Pharmaceutical Nimodipine for Injection Products Offered
10.5.5 Kunming Longjin Pharmaceutical Recent Development
10.6 Hainan Poly Pharm
10.6.1 Hainan Poly Pharm Company Information
10.6.2 Hainan Poly Pharm Introduction and Business Overview
10.6.3 Hainan Poly Pharm Nimodipine for Injection Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Hainan Poly Pharm Nimodipine for Injection Products Offered
10.6.5 Hainan Poly Pharm Recent Development
10.7 Shanxi Zhendong Taisheng Pharmaceutical
10.7.1 Shanxi Zhendong Taisheng Pharmaceutical Company Information
10.7.2 Shanxi Zhendong Taisheng Pharmaceutical Introduction and Business Overview
10.7.3 Shanxi Zhendong Taisheng Pharmaceutical Nimodipine for Injection Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Shanxi Zhendong Taisheng Pharmaceutical Nimodipine for Injection Products Offered
10.7.5 Shanxi Zhendong Taisheng Pharmaceutical Recent Development
10.8 Hainan Brilliant Pharmaceutical
10.8.1 Hainan Brilliant Pharmaceutical Company Information
10.8.2 Hainan Brilliant Pharmaceutical Introduction and Business Overview
10.8.3 Hainan Brilliant Pharmaceutical Nimodipine for Injection Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Hainan Brilliant Pharmaceutical Nimodipine for Injection Products Offered
10.8.5 Hainan Brilliant Pharmaceutical Recent Development
10.9 Fujian Mindong Rejuenation Pharmaceutical
10.9.1 Fujian Mindong Rejuenation Pharmaceutical Company Information
10.9.2 Fujian Mindong Rejuenation Pharmaceutical Introduction and Business Overview
10.9.3 Fujian Mindong Rejuenation Pharmaceutical Nimodipine for Injection Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Fujian Mindong Rejuenation Pharmaceutical Nimodipine for Injection Products Offered
10.9.5 Fujian Mindong Rejuenation Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nimodipine for Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nimodipine for Injection Industrial Chain Analysis
11.4 Nimodipine for Injection Market Dynamics
11.4.1 Nimodipine for Injection Industry Trends
11.4.2 Nimodipine for Injection Market Drivers
11.4.3 Nimodipine for Injection Market Challenges
11.4.4 Nimodipine for Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nimodipine for Injection Distributors
12.3 Nimodipine for Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 2mg/Bottle
Table 2. Major Company of 4mg/Bottle
Table 3. Global Nimodipine for Injection Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Nimodipine for Injection Sales by Type (2024-2024) & (K Units)
Table 5. Global Nimodipine for Injection Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Nimodipine for Injection Sales by Type (2024-2024) & (US& Million)
Table 7. Global Nimodipine for Injection Market Share in Value by Type (2024-2024)
Table 8. Global Nimodipine for Injection Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Nimodipine for Injection Sales by Type (2024-2034) & (K Units)
Table 10. Global Nimodipine for Injection Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Nimodipine for Injection Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Nimodipine for Injection Sales Market Share in Value by Type (2024-2034)
Table 13. Global Nimodipine for Injection Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Nimodipine for Injection Sales by Type (2024-2024) & (K Units)
Table 15. North America Nimodipine for Injection Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Nimodipine for Injection Sales (K Units) by Type (2024-2024)
Table 17. Europe Nimodipine for Injection Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Nimodipine for Injection Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Nimodipine for Injection Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Nimodipine for Injection Sales (K Units) by Type (2024-2024)
Table 21. Latin America Nimodipine for Injection Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Nimodipine for Injection Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Nimodipine for Injection Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Nimodipine for Injection Sales by Company (2024-2024) & (K Units)
Table 25. Global Nimodipine for Injection Sales Share by Company (2024-2024)
Table 26. Global Nimodipine for Injection Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Nimodipine for Injection Revenue Share by Company (2024-2024)
Table 28. Global Market Nimodipine for Injection Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Nimodipine for Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Nimodipine for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nimodipine for Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Nimodipine for Injection Market
Table 33. Key Manufacturers Nimodipine for Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Nimodipine for Injection Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Nimodipine for Injection Sales by Region (2024-2024) & (K Units)
Table 37. Global Nimodipine for Injection Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Nimodipine for Injection Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Nimodipine for Injection Sales Market Share in Value by Region (2024-2024)
Table 40. Global Nimodipine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Nimodipine for Injection Sales by Region (2024-2034) & (K Units)
Table 42. Global Nimodipine for Injection Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Nimodipine for Injection Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Nimodipine for Injection Sales Market Share in Value by Region (2024-2034)
Table 45. Global Nimodipine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Nimodipine for Injection Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Nimodipine for Injection Sales by Application (2024-2024) & (K Units)
Table 48. Global Nimodipine for Injection Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Nimodipine for Injection Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Nimodipine for Injection Sales Market Share in Value by Application (2024-2024)
Table 51. Global Nimodipine for Injection Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Nimodipine for Injection Sales by Application (2024-2034) & (K Units)
Table 53. Global Nimodipine for Injection Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Nimodipine for Injection Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Nimodipine for Injection Sales Market Share in Value by Application (2024-2034)
Table 56. Global Nimodipine for Injection Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Nimodipine for Injection Sales by Application (2024-2024) (K Units)
Table 58. North America Nimodipine for Injection Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Nimodipine for Injection Sales by Application (2024-2024) (K Units)
Table 60. Europe Nimodipine for Injection Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Nimodipine for Injection Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Nimodipine for Injection Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Nimodipine for Injection Sales by Application (2024-2024) (K Units)
Table 64. Latin America Nimodipine for Injection Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Nimodipine for Injection Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Nimodipine for Injection Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Nimodipine for Injection Sales by Country (2024-2024) & (K Units)
Table 68. North America Nimodipine for Injection Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Nimodipine for Injection Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Nimodipine for Injection Sales Market Share in Value by Country (2024-2024)
Table 71. North America Nimodipine for Injection Sales by Country (2024-2034) & (K Units)
Table 72. North America Nimodipine for Injection Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Nimodipine for Injection Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Nimodipine for Injection Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Nimodipine for Injection Sales by Country (2024-2024) & (K Units)
Table 76. Europe Nimodipine for Injection Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Nimodipine for Injection Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Nimodipine for Injection Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Nimodipine for Injection Sales by Country (2024-2034) & (K Units)
Table 80. Europe Nimodipine for Injection Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Nimodipine for Injection Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Nimodipine for Injection Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Nimodipine for Injection Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Nimodipine for Injection Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Nimodipine for Injection Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Nimodipine for Injection Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Nimodipine for Injection Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Nimodipine for Injection Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Nimodipine for Injection Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Nimodipine for Injection Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Nimodipine for Injection Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Nimodipine for Injection Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Nimodipine for Injection Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Nimodipine for Injection Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Nimodipine for Injection Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Nimodipine for Injection Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Nimodipine for Injection Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Nimodipine for Injection Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Nimodipine for Injection Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Nimodipine for Injection Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Nimodipine for Injection Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Nimodipine for Injection Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Nimodipine for Injection Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Nimodipine for Injection Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Nimodipine for Injection Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Nimodipine for Injection Sales Market Share in Value by Country (2024-2034)
Table 107. Shanxi PUDE Pharmaceutical Company Information
Table 108. Shanxi PUDE Pharmaceutical Introduction and Business Overview
Table 109. Shanxi PUDE Pharmaceutical Nimodipine for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Shanxi PUDE Pharmaceutical Nimodipine for Injection Product
Table 111. Shanxi PUDE Pharmaceutical Recent Development
Table 112. Reyoung Pharmaceutical Company Information
Table 113. Reyoung Pharmaceutical Introduction and Business Overview
Table 114. Reyoung Pharmaceutical Nimodipine for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Reyoung Pharmaceutical Nimodipine for Injection Product
Table 116. Reyoung Pharmaceutical Recent Development
Table 117. Double-Crane Pharmaceutical(Hainan) Company Information
Table 118. Double-Crane Pharmaceutical(Hainan) Introduction and Business Overview
Table 119. Double-Crane Pharmaceutical(Hainan) Nimodipine for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Double-Crane Pharmaceutical(Hainan) Nimodipine for Injection Product
Table 121. Double-Crane Pharmaceutical(Hainan) Recent Development
Table 122. Shanxi Hengda Pharmaceutical Company Information
Table 123. Shanxi Hengda Pharmaceutical Introduction and Business Overview
Table 124. Shanxi Hengda Pharmaceutical Nimodipine for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Shanxi Hengda Pharmaceutical Nimodipine for Injection Product
Table 126. Shanxi Hengda Pharmaceutical Recent Development
Table 127. Kunming Longjin Pharmaceutical Company Information
Table 128. Kunming Longjin Pharmaceutical Introduction and Business Overview
Table 129. Kunming Longjin Pharmaceutical Nimodipine for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Kunming Longjin Pharmaceutical Nimodipine for Injection Product
Table 131. Kunming Longjin Pharmaceutical Recent Development
Table 132. Hainan Poly Pharm Company Information
Table 133. Hainan Poly Pharm Introduction and Business Overview
Table 134. Hainan Poly Pharm Nimodipine for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Hainan Poly Pharm Nimodipine for Injection Product
Table 136. Hainan Poly Pharm Recent Development
Table 137. Shanxi Zhendong Taisheng Pharmaceutical Company Information
Table 138. Shanxi Zhendong Taisheng Pharmaceutical Introduction and Business Overview
Table 139. Shanxi Zhendong Taisheng Pharmaceutical Nimodipine for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Shanxi Zhendong Taisheng Pharmaceutical Nimodipine for Injection Product
Table 141. Shanxi Zhendong Taisheng Pharmaceutical Recent Development
Table 142. Hainan Brilliant Pharmaceutical Company Information
Table 143. Hainan Brilliant Pharmaceutical Introduction and Business Overview
Table 144. Hainan Brilliant Pharmaceutical Nimodipine for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Hainan Brilliant Pharmaceutical Nimodipine for Injection Product
Table 146. Hainan Brilliant Pharmaceutical Recent Development
Table 147. Fujian Mindong Rejuenation Pharmaceutical Company Information
Table 148. Fujian Mindong Rejuenation Pharmaceutical Introduction and Business Overview
Table 149. Fujian Mindong Rejuenation Pharmaceutical Nimodipine for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Fujian Mindong Rejuenation Pharmaceutical Nimodipine for Injection Product
Table 151. Fujian Mindong Rejuenation Pharmaceutical Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Nimodipine for Injection Market Trends
Table 155. Nimodipine for Injection Market Drivers
Table 156. Nimodipine for Injection Market Challenges
Table 157. Nimodipine for Injection Market Restraints
Table 158. Nimodipine for Injection Distributors List
Table 159. Nimodipine for Injection Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Nimodipine for Injection Product Picture
Figure 2. Global Nimodipine for Injection Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Nimodipine for Injection Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Nimodipine for Injection Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of 2mg/Bottle
Figure 6. Global 2mg/Bottle Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of 4mg/Bottle
Figure 8. Global 4mg/Bottle Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Nimodipine for Injection Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Nimodipine for Injection Sales Market Share by Type in 2022 & 2034
Figure 11. North America Nimodipine for Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Nimodipine for Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Nimodipine for Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Nimodipine for Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Nimodipine for Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Nimodipine for Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Nimodipine for Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Nimodipine for Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Nimodipine for Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Nimodipine for Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Nimodipine for Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Nimodipine for Injection Revenue in 2022
Figure 23. Nimodipine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital Pharmacy
Figure 25. Global Hospital Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Retail Pharmacy
Figure 27. Global Retail Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Nimodipine for Injection Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Nimodipine for Injection Sales Market Share by Application in 2022 & 2034
Figure 32. North America Nimodipine for Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America Nimodipine for Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe Nimodipine for Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe Nimodipine for Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Nimodipine for Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Nimodipine for Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America Nimodipine for Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Nimodipine for Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Nimodipine for Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Nimodipine for Injection Manufacturing Cost Structure
Figure 43. Nimodipine for Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed